Register

COURSE DESCRIPTION:  

Since first patients with AIDS were reported in 1981, HIV infection has developed into one of the greatest pandemics in modern times with devastating socioeconomic and demographic consequences. Currently, a total of 75 million people has become infected with HIV worldwide and 32 million have died of AIDS. In 2019, 1.7 million individuals became newly infected and some 38 million live with HIV, of whom not all have access to ART. Please join us to discuss how to appropriately screen and diagnose patients with HIV as well as identify the unique primary care needs of people with HIV. 

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents, Dentists, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

• Appropriately screen and diagnose patients with HIV. 
• Identify candidates who would be appropriate for Pre-exposure prophylaxis (PrEP).
• Select a HIV regimen for a patient newly diagnosed with HIV.
• Identify the unique primary care needs of people with HIV.
   

FACULTY AND DISCLOSURES:

William Short, M.D. MPH, FIDSA                                                                       
Faculty
Pennsylvania Mid-Atlantic AIDs Education and Training Center 
Associate Professor of Clinical Medicine, University of Pennsylvania School of Medicine
Associate Professor of Clinical Medicine in Obstetrics and Gynecology, University of Pennsylvania School of Medicine (Secondary)
Clinical Associate, School of Nursing
Attending Physician, Partnership Comprehensive Care Practice, Hospital of the University of Pennsylvania, and Helen O. Dickens Center for Women, Hospital of the University of Pennsylvania
Co-Chair Infectious Diseases CME Conference, Perelman School of Medicine
Associate Director & Co-Investigator, AIDS Clinical Trial Unit (ACTU) research site, University of Pennsylvania
Philadelphia, Pennsylvania

William Short, M.D. MPH, FIDSA, faculty for this educational activity, indicated that he is a researcher for Gilead Sciences. He is also an advisor for ViiV and Gilead Sciences. Dr. Short has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.

All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.